Sathekge MM - Search Results

1

Can current preclinical strategies for radiopharmaceutical development meet the needs of targeted alpha therapy?

Kleynhans J, Ebenhan T, Cleeren F, Sathekge MM. Kleynhans J, et al. Among authors: sathekge mm. Eur J Nucl Med Mol Imaging. 2024 Apr 27. doi: 10.1007/s00259-024-06719-5. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 38676735 Review.

2

Letter from the Editors.

Bouchelouche K, Sathekge MM. Bouchelouche K, et al. Among authors: sathekge mm. Semin Nucl Med. 2024 May;54(3):311-312. doi: 10.1053/j.semnuclmed.2024.04.002. Epub 2024 Apr 26. Semin Nucl Med. 2024. PMID: 38670819 No abstract available.

3

Prostate-specific Membrane Antigen: Alpha-labeled Radiopharmaceuticals.

Ndlovu H, Mokoala KMG, Lawal I, Emmett L, Sathekge MM. Ndlovu H, et al. Among authors: sathekge mm. PET Clin. 2024 Apr 23:S1556-8598(24)00018-X. doi: 10.1016/j.cpet.2024.03.003. Online ahead of print. PET Clin. 2024. PMID: 38658230 Review.

4

Advances in Radioligand Theranostics in Oncology.

Lawal IO, Abubakar SO, Ndlovu H, Mokoala KMG, More SS, Sathekge MM. Lawal IO, et al. Among authors: sathekge mm. Mol Diagn Ther. 2024 May;28(3):265-289. doi: 10.1007/s40291-024-00702-4. Epub 2024 Mar 31. Mol Diagn Ther. 2024. PMID: 38555542 Review.

5

Letter From the Editors.

Sathekge MM, Bouchelouche K. Sathekge MM, et al. Semin Nucl Med. 2024 Mar;54(2):183. doi: 10.1053/j.semnuclmed.2024.01.009. Epub 2024 Feb 14. Semin Nucl Med. 2024. PMID: 38360441 No abstract available.

6

Imaging Molecular Targets and Metabolic Pathways in Breast Cancer for Improved Clinical Management: Current Practice and Future Perspectives.

Ndlovu H, Lawal IO, Mokoala KMG, Sathekge MM. Ndlovu H, et al. Among authors: sathekge mm. Int J Mol Sci. 2024 Jan 26;25(3):1575. doi: 10.3390/ijms25031575. Int J Mol Sci. 2024. PMID: 38338854 Free PMC article. Review.

7

Insights into Peptidoglycan-Targeting Radiotracers for Imaging Bacterial Infections: Updates, Challenges, and Future Perspectives.

Koatale PC, Welling MM, Ndlovu H, Kgatle M, Mdanda S, Mdlophane A, Okem A, Takyi-Williams J, Sathekge MM, Ebenhan T. Koatale PC, et al. Among authors: sathekge mm. ACS Infect Dis. 2024 Feb 9;10(2):270-286. doi: 10.1021/acsinfecdis.3c00443. Epub 2024 Jan 30. ACS Infect Dis. 2024. PMID: 38290525 Free PMC article. Review.

8

Global Research Output of Lutetium-177 PSMA in Prostate Cancer: Bibliometric and Altmetric Analyses.

Al-Rashdan R, Al-Abdallat H, Sathekge MM, Mirzaei S, Shahait M, Al-Khawaldeh K, Abdlkadir AS, Lee S, Al-Ibraheem A. Al-Rashdan R, et al. Among authors: sathekge mm. Nuklearmedizin. 2024 Jan 23. doi: 10.1055/a-2221-3036. Online ahead of print. Nuklearmedizin. 2024. PMID: 38262473 English.

9

Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study.

Sathekge MM, Lawal IO, Bal C, Bruchertseifer F, Ballal S, Cardaci G, Davis C, Eiber M, Hekimsoy T, Knoesen O, Kratochwil C, Lenzo NP, Mahapane J, Maserumule LC, Mdlophane AH, Mokoala KMG, Ndlovu H, Pant V, Rathke H, Reed J, Sen IB, Singh A, Sood A, Tauber R, Thakral P, Yadav MP, Morgenstern A. Sathekge MM, et al. Lancet Oncol. 2024 Feb;25(2):175-183. doi: 10.1016/S1470-2045(23)00638-1. Epub 2024 Jan 11. Lancet Oncol. 2024. PMID: 38218192

10

Letter From the Editors.

Bouchelouche K, Sathekge MM. Bouchelouche K, et al. Among authors: sathekge mm. Semin Nucl Med. 2024 Jan;54(1):1-3. doi: 10.1053/j.semnuclmed.2023.11.006. Semin Nucl Med. 2024. PMID: 38065626 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

144 results

Search Page